This is a limited company view. Sign up for a Free Trial to see everything.

Tioga Pharmaceuticals is planning to conduct a phase 2 trial of its selective kappa-opioid receptor agonist, asimadoline, for the treatment of associated with atopic pruritus.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

San Diego

Founded

Employees

3

Stage

Series B

Total funding

$52M

Last funding

6 years ago

Acquisitions

0

Growth score

-2

Mindshare score

0

Scoring

Employee Growth

Use Tioga Pharmaceuticals's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Tioga Pharmaceuticals's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial